[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15610]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-06650]



[[Page 15610]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Initial Review
    The meeting announced below concerns Cooperative Research 
Agreements to the World Trade Center Health Program (U01) PAR 12-126, 
initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date:

8:00 a.m.-5:00 p.m., April 14, 2015 (Closed)
8:00 a.m.-12:00 p.m., April 15, 2015 (Closed)

    Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE., 
Atlanta, Georgia 30345, Telephone: (404) 325-0000.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Cooperative Research Agreements Related to the World Trade Center 
Health Program (U01) PAR 12-126.''
    Contact Person for More Information: Nina Turner, Ph.D., Scientific 
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-06650 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P